National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

This is VAERS ID 1773406

Government Disclaimer on use of this data

Case Details

VAERS ID: 1773406 (history)  
Form: Version 2.0  
Sex: Female  
Location: South Carolina  
Submitted: 0000-00-00
Entered: 2021-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1822809 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Dizziness, Headache, Hypertension, Injection site pruritus, Injection site reaction, Nausea
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypertension (narrow), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Test Date: 202110; Test Name: Blood pressure; Result Unstructured Data: high
CDC Split Type: USJNJFOC20211014251

Write-up: ITCHING AT SITE OF INJECTION; OOZING SITE OF INJECTION; DIZZINESS; HIGH BLOOD PRESSURE; NAUSEA; HEADACHES; This spontaneous report received from a patient concerned a 34 year old female. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: UNKNOWN) dose was not reported, administered on 05-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On OCT-2021, the patient experienced itching at site of injection. On OCT-2021, the patient experienced oozing site of injection. On OCT-2021, the patient experienced dizziness. On OCT-2021, the patient experienced high blood pressure. On OCT-2021, the patient experienced nausea. On OCT-2021, the patient experienced headaches. Laboratory data included: Blood pressure (NR: not provided) high. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching at site of injection, oozing site of injection, nausea, dizziness, headaches, and high blood pressure. This report was non-serious. This case, from the same reporter is linked to 20211014731.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166